The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guerder, S.
Right arrow Articles by Flavell, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guerder, S.
Right arrow Articles by Flavell, R. A.
The Journal of Immunology, 1998, 161: 2128-2140.
Copyright © 1998 by The American Association of Immunologists

Autoimmunity Without Diabetes in Transgenic Mice Expressing ß Cell-Specific CD86, But Not CD80: Parameters that Trigger Progression to Diabetes1

Sylvie Guerder2,3,*, Elizabeth E. Eynon2,* and Richard A. Flavell4,*,{dagger}

* Section of Immunobiology and {dagger} Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520

To define more clearly the roles of CD80 (RIP-CD80) and CD86 (RIP-CD86) in the activation of autoreactive T cells in vivo, we generated transgenic mice expressing either or both costimulatory molecules on the ß cells of the pancreas. While RIP-CD80 mice do not show any sign of autoimmunity, at the age of 7 mo RIP-CD86 transgenic mice develop a lymphoid infiltrate with both IFN-{gamma}- and IL-4-positive cells in the vicinity of the islets; these mice, however, never progress to diabetes. This fundamental difference in the ability of CD80 and CD86 to activate self-reactive T cells in vivo is, however, obliterated when the level of TCR signaling is increased by either TNF-{alpha} or transgenic MHC class II expression. These results support the suggestion that CD80 and CD86 mainly differ at the level of the intensity of the signals they deliver.




This article has been cited by other articles:


Home page
J. Immunol.Home page
I. J. Thomas, L. G. Petrich de Marquesini, R. Ravanan, R. M. Smith, S. Guerder, R. A. Flavell, D. C. Wraith, L. Wen, and F. S. Wong
CD86 Has Sustained Costimulatory Effects on CD8 T Cells
J. Immunol., November 1, 2007; 179(9): 5936 - 5946.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Sun, B. Tumurbaatar, J. Jia, H. Diao, F. Bodola, S. M. Lemon, W. Tang, D. G. Bowen, G. W. McCaughan, P. Bertolino, et al.
Parenchymal Expression of CD86/B7.2 Contributes to Hepatitis C Virus-Related Liver Injury
J. Virol., August 15, 2005; 79(16): 10730 - 10739.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Stephens and D. D. Chaplin
IgE Cross-Linking or Lipopolysaccharide Treatment Induces Recruitment of Th2 Cells to the Lung in the Absence of Specific Antigen
J. Immunol., November 15, 2002; 169(10): 5468 - 5476.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Kitani, K. Chua, K. Nakamura, and W. Strober
Activated Self-MHC-Reactive T Cells Have the Cytokine Phenotype of Th3/T Regulatory Cell 1 T Cells
J. Immunol., July 15, 2000; 165(2): 691 - 702.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. D. Schell, L. M. Mylin, I. Georgoff, A. K. Teresky, A. J. Levine, and S. S. Tevethia
Cytotoxic T-Lymphocyte Epitope Immunodominance in the Control of Choroid Plexus Tumors in Simian Virus 40 Large T Antigen Transgenic Mice
J. Virol., July 1, 1999; 73(7): 5981 - 5993.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.